Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, indicating an update to the page metadata. This reflects an administrative update to the record rather than changes to the study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now shows a new revision tag v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision history metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s UI/version footer was updated from revision v3.5.2 to v3.5.3. This reflects a technical site update rather than any change to the underlying clinical trial record.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

- Check82 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check96 days agoChange DetectedThe record history shows a new revision v3.4.3 added, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.